Published in Am J Ophthalmol on December 01, 2000
Corneal pachymetry mapping with high-speed optical coherence tomography. Ophthalmology (2006) 2.24
Optical coherence tomography in malignant glaucoma following filtration surgery. Br J Ophthalmol (2003) 0.94
Measuring Corneal Thickness with SOCT, the Scheimpflug System, and Ultrasound Pachymetry. ISRN Ophthalmol (2012) 0.88
[Reproducibility of goniometry with slitlamp-adapted optical coherence tomography]. Ophthalmologe (2004) 0.82
Optical coherence tomography of the Ex-PRESS miniature glaucoma implant. Lasers Med Sci (2005) 0.82
Assessment of anterior segment parameters under photopic and scotopic conditions in Indian eyes using anterior segment optical coherence tomography. Indian J Ophthalmol (2007) 0.80
Online optical coherence pachymetry to evaluate intraoperative ablation parameters in LASIK. Graefes Arch Clin Exp Ophthalmol (2006) 0.77
[Biometry of the anterior segment using optical coherence tomography : Evaluation of different devices and analysis programs]. Ophthalmologe (2009) 0.77
Central corneal thickness in southern Egypt. Int Ophthalmol (2013) 0.76
Experimental evaluation of online optical coherence pachymetry for corneal refractive surgery. Graefes Arch Clin Exp Ophthalmol (2003) 0.76
[Online optical coherence pachymetry in laser in situ keratomileusis]. Ophthalmologe (2004) 0.75
Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: preoperative and postoperative ultrasound biomicroscopic examination and short-term clinical outcomes with and without an antihyperopia treatment. Trans Am Ophthalmol Soc (2003) 0.75
Enhancement of Corneal Visibility in Optical Coherence Tomography Images with Corneal Opacification. Transl Vis Sci Technol (2016) 0.75
Anterior Segment Optical Coherence Tomography and its Clinical Applications in Glaucoma. J Curr Glaucoma Pract (2012) 0.75
Real-time imaging of transscleral diode laser cyclophotocoagulation by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2006) 0.75
Comparison of Central Corneal Thickness using Anterior Segment Optical Coherence Tomography Versus Ultrasound Pachymetry. J Clin Diagn Res (2017) 0.75
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.96
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.92
A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol (1997) 2.70
Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol (1975) 2.63
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
The GroE chaperonin machine is a major modulator of the CIRCE heat shock regulon of Bacillus subtilis. EMBO J (1997) 2.50
[Scleral buckling surgery and pneumatic retinopexy. Techniques, indications and results]. Ophthalmologe (2008) 2.46
Rapid isolation of highly active RNA polymerase from Escherichia coli and its subunits by matrix-bound heparin. Eur J Biochem (1975) 1.92
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics (1998) 1.84
Nd:YAG laser photodisruption of hemorrhagic detachment of the internal limiting membrane. Am J Ophthalmol (1989) 1.84
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol (1999) 1.80
The activation of female sex hormones: alpha-Oestradiol and its di-esters. Biochem J (1938) 1.69
Secondary paracentral retinal holes following internal limiting membrane removal. Br J Ophthalmol (2006) 1.59
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53
Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol (1975) 1.50
The activation of female sex hormones: Oestrone and its esters. The output of activity and efficiency coefficient. Biochem J (1938) 1.49
Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol (1992) 1.48
Slc26a3 deficiency is associated with loss of colonic HCO3 (-) secretion, absence of a firm mucus layer and barrier impairment in mice. Acta Physiol (Oxf) (2014) 1.48
Combined choroidal and retinal ischemia during interferon therapy: indocyanine green angiographic and microperimetric findings. Arch Ophthalmol (2000) 1.45
Optical coherence tomography of the human skin. J Am Acad Dermatol (1997) 1.37
Optical properties of human sclera, and their consequences for transscleral laser applications. Lasers Surg Med (1991) 1.35
Thermal and biomechanical parameters of porcine cornea. Cornea (2000) 1.34
Corneal ablation by nanosecond, picosecond, and femtosecond lasers at 532 and 625 nm. Arch Ophthalmol (1989) 1.33
Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol (2000) 1.31
Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol (2000) 1.29
Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca. Ophthalmology (1998) 1.27
Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology (1994) 1.27
Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur J Cancer (1996) 1.26
Repair and adhesion mechanisms of the cryotherapy lesion in experimental retinal detachment. Am J Ophthalmol (1976) 1.26
Defective jejunal and colonic salt absorption and alteredNa(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. Pflugers Arch (2008) 1.26
[Individual differences in light absorption in the fundus oculi in the visible and the infrared spectral region]. Ber Zusammenkunft Dtsch Ophthalmol Ges (1977) 1.25
Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg Med (2000) 1.25
Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol (1987) 1.23
Induction of metronidazole and furazolidone resistance in Giardia. Trans R Soc Trop Med Hyg (1993) 1.23
Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 1.22
The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533. Am J Hum Genet (1992) 1.22
Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat (2006) 1.21
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
Mechanisms of intraocular photodisruption with picosecond and nanosecond laser pulses. Lasers Surg Med (1994) 1.20
Slit-lamp-adapted optical coherence tomography of the anterior segment. Graefes Arch Clin Exp Ophthalmol (2000) 1.19
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell (1997) 1.18
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res (2001) 1.17
N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci (1999) 1.16
Intraocular photodisruption with picosecond and nanosecond laser pulses: tissue effects in cornea, lens, and retina. Invest Ophthalmol Vis Sci (1994) 1.16
Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci U S A (1993) 1.15
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis (2005) 1.15
Clinical-pathological correlation in massive periretinal proliferation. Am J Ophthalmol (1975) 1.13
Dynamic association of trigger factor with protein substrates. J Mol Biol (2001) 1.11
Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol (1999) 1.09
Empirical development and evaluation of prehospital trauma triage instruments. J Trauma (1985) 1.09
Tumors and tumor-like lesions of the retinal pigment epithelium. Ophthalmologica (1981) 1.08
Delayed intraocular lens dislocation after neodymium:YAG capsulotomy. J Cataract Refract Surg (1998) 1.08
Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol (1998) 1.08
Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases. Transfus Sci (2000) 1.07
Semiconductor diode laser photocoagulation in retinal vascular disease. Ophthalmology (1990) 1.07
Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology (1994) 1.06
Treatment of traumatic cyclodialysis with vitrectomy, cryotherapy, and gas endotamponade. J Cataract Refract Surg (1999) 1.04
In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med (1995) 1.01
Congenital retino-pigment epithelial malformation, previously described as hamartoma. Am J Ophthalmol (1979) 1.01
A logical approach to the treatment of massive periretinal proliferation. Ophthalmology (1978) 1.01
Nine cases of cavernous hemangioma of the retina. Am J Ophthalmol (1983) 1.01
Mapping of the autosomal dominant exudative vitreoretinopathy locus (EVR1) by multipoint linkage analysis in four families. Genomics (1994) 0.99
Tracer test with As(V) under variable redox conditions controlling arsenic transport in the presence of elevated ferrous iron concentrations. J Contam Hydrol (2006) 0.99
Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results. Bull Soc Belge Ophtalmol (2006) 0.99
Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol (2002) 0.99
The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11. Am J Ophthalmol (1992) 0.99
Corneal shape changes after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (1998) 0.98
Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients. Blood (1997) 0.97
Peripheral retinal telangiectasis in adults simulating a vascular tumor or melanoma. Ophthalmology (1983) 0.97
Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions. Biochemistry (1998) 0.97
Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. Pharmacogenetics (1996) 0.96
Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood (1984) 0.96
New bioresorbable pin for the reduction of small bony fragments: design, mechanical properties and in vitro degradation. Biomaterials (1996) 0.96
Experimental studies of laser thermal retinal injury. Health Phys (1983) 0.96
Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 0.95
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant (1995) 0.95
Treatment of cancer patients with endotoxin induces release of endogenous cytokines. Pathobiology (1991) 0.95
First experimental and clinical results with transscleral optical coherence tomography. Ophthalmic Surg Lasers (2000) 0.95
Argon laser retinal lesions evaluated in vivo by optical coherence tomography. Am J Ophthalmol (1997) 0.94
Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer (1997) 0.94